Acquisition by Bahija Jallal of 281819 shares of Immunocore Holdings at 70.5 subject to Rule 16b-3
| IMCR Stock | USD 32.83 0.38 1.17% |
Slightly above 56% of all Immunocore Holdings' retail investors are looking to take a long position. The analysis of the overall investor sentiment regarding Immunocore Holdings suggests that some traders are interested. Immunocore Holdings' investing sentiment overview a quick insight into current market opportunities from investing in Immunocore Holdings. Many technical investors use Immunocore Holdings stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Immunocore |
Filed transaction by Immunocore Holdings Director, Officer: Chief Executive Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Cash Flow Correlation
Immunocore Holdings' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Immunocore Holdings' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Immunocore Holdings Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Immunocore Holdings can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Immunocore Holdings Fundamental Analysis
We analyze Immunocore Holdings' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immunocore Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immunocore Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
Immunocore Holdings is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Immunocore Holdings Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Immunocore Holdings stock to make a market-neutral strategy. Peer analysis of Immunocore Holdings could also be used in its relative valuation, which is a method of valuing Immunocore Holdings by comparing valuation metrics with similar companies.
Peers
Immunocore Holdings Related Equities
| LRMR | Larimar Therapeutics | 7.44 | ||||
| GLUE | Monte Rosa | 5.93 | ||||
| ERAS | Erasca | 5.04 | ||||
| VTYX | Ventyx Biosciences | 4.33 | ||||
| MIRM | Mirum Pharmaceuticals | 3.32 | ||||
| PCVX | Vaxcyte | 2.77 | ||||
| KALV | Kalvista Pharmaceuticals | 1.10 | ||||
| NUVL | Nuvalent | 0.48 | ||||
| VRDN | Viridian Therapeutics | 0.18 | ||||
| ACLX | Arcellx | 2.08 | ||||
| DSGN | Design Therapeutics | 2.93 | ||||
| LYRA | Lyra Therapeutics | 5.00 |
Additional Tools for Immunocore Stock Analysis
When running Immunocore Holdings' price analysis, check to measure Immunocore Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunocore Holdings is operating at the current time. Most of Immunocore Holdings' value examination focuses on studying past and present price action to predict the probability of Immunocore Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunocore Holdings' price. Additionally, you may evaluate how the addition of Immunocore Holdings to your portfolios can decrease your overall portfolio volatility.